Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Tango Therapeutics (TNGX) Gross Profit: 2020-2024

Historic Gross Profit for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to $42.1 million.

  • Tango Therapeutics' Gross Profit rose 363.61% to $53.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.5 million, marking a year-over-year increase of 53.28%. This contributed to the annual value of $42.1 million for FY2024, which is 15.17% up from last year.
  • According to the latest figures from FY2024, Tango Therapeutics' Gross Profit is $42.1 million, which was up 15.17% from $36.5 million recorded in FY2023.
  • In the past 5 years, Tango Therapeutics' Gross Profit registered a high of $42.1 million during FY2024, and its lowest value of $7.7 million during FY2020.
  • In the last 3 years, Tango Therapeutics' Gross Profit had a median value of $36.5 million in 2023 and averaged $34.5 million.
  • Per our database at Business Quant, Tango Therapeutics' Gross Profit soared by 383.83% in 2021 and then plummeted by 32.89% in 2022.
  • Yearly analysis of 5 years shows Tango Therapeutics' Gross Profit stood at $7.7 million in 2020, then surged by 383.83% to $37.0 million in 2021, then tumbled by 32.89% to $24.9 million in 2022, then soared by 46.93% to $36.5 million in 2023, then increased by 15.17% to $42.1 million in 2024.